Electrochemical Biosensors Show Promise in Early Cancer Detection

According to a recent study published in the Microchemical Journal, electrochemical biosensors have emerged as promising diagnostic tools in oncology research. These devices offer rapid response, high sensitivity, multiplexing capabilities, and potential for miniaturization, making them ideal for early cancer detection and monitoring. The study, led by researchers at the University of Tehran, focuses on the use of electrochemical biosensors for detecting tumor-specific biomarkers, with a specific emphasis on colorectal cancer (CRC). The research highlights the potential of electrochemical biosensors in improving clinical decision-making by providing accurate measurement of biomarkers at various stages of the disease.

Key Takeaways:

• Electrochemical biosensors have shown promise in early cancer detection and monitoring, particularly for CRC.
• The devices offer rapid response, high sensitivity, multiplexing capabilities, and potential for miniaturization.
• Innovations in immunoassay-based EBs have shown their ability to detect tumor-specific biomarkers with precision, supporting early diagnosis, disease staging, and prognosis.
• Ongoing efforts are focused on designing EBs that offer simple, cost-effective, and accessible methods for cancer biomarker detection.
• The study highlights various CRC biomarkers incorporated into EB platforms and discusses their potential for improving clinical decision-making.
• Researchers at the University of Tehran, led by Hamid Rashedi, are at the forefront of this research, working alongside Helena Alamdari, Naghmeh Khodabandeh Lu, Mehrab Pourmadadi, and Fatemeh Yazdian.

Statistics:

• Cancer is a leading cause of global mortality, particularly in developing countries.
• The study highlights the importance of biomarker-based genetic and immunoassay techniques in modern cancer diagnostics.
• Biomarkers such as CA-19-9 and CEA are routinely applied in clinical practice for CRC.
• Electrochemical biosensors detect tumor-specific biomarkers with precision, supporting early diagnosis, disease staging, and prognosis.
• The research has been peer-reviewed and published in the Microchemical Journal.

Sources:

• NewsRx. New Electrochemical Biosensors Study Findings Recently Were Reported by Researchers at University of Tehran (Electrochemical Biosensors for Biomarker Monitoring, With a Specific Focus On Colorectal Cancer: Toward Innovative Primary Screening ...). Cancer Weekly. July 8, 2025; p 360.
• Microchemical Journal. Electrochemical Biosensors for Biomarker Monitoring, With a Specific Focus On Colorectal Cancer: Toward Innovative Primary Screening Approaches. 2025;214.
• University of Tehran. College of Engineering, School of Chemical Engineering, Dept. of Biotechnologies, Tehran, Iran.